Influenza B virus B/Phuket/3073/2013 live (attenuated) antigen

DB11036ApprovedVaccines

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".

First approval
United States, 2015
Also known as
influenza B virus B/Phuket/3073/2013 antigen
Brand names
  • FluMist Quadrivalent

Resolves to

Compound
UNII91E648A88W
Clinical / RWD
RxNorm1657228

What you can answer from here — as of June 04, 2026

19Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
16Marketed productsAcross 4 countries and 3 labellers
Sign in

Which other approved drugs treat the same conditions as Influenza B virus B/Phuket/3073/2013 live (attenuated) antigen, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In